Butalbital compound vs Tositumomab and Iodine I 131 Tositumomab

Interacting Drugs
Butalbital compound
vs
Tositumomab and Iodine I 131 Tositumomab
Security Level
Minor, Monitor Therapy
Mechanism
Tositumomab and Iodine I 131 Tositumomab: Antiplatelet Agents may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Butalbital compound vs Tositumomab and Iodine I 131 Tositumomab


Other Interactions of Butalbital compound

We are Developing Our database, More results coming soon.

Other Interactions of Tositumomab and Iodine I 131 Tositumomab

We are Developing Our database, More results coming soon.